Expression of TLR-4 and -2 in peripheral mononuclear cells in renal transplant patients with TLR-4 gene polymorphism


Autoria(s): NOGUEIRA, Eliana; SALOMAO, Reinaldo; BRUNIALTI, Milena Karina Collo; OZAKI, Kikumi S.; MARQUES, Georgia D. M.; CENEDEZE, Marcos A.; CAMARA, Niels Olsen Saraiva; PACHECO-SILVA, Alvaro
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Introduction: TLR-4 has also been identified as a receptor for endogenous alarmins, which are increased post transplantation. TLR-4 has also been associated with a polymorphism that could impact graft outcome. Objective: To assess the expression of TLR-4 in kidney transplant patients carrying or not a polymorphism. Methods: TLR-4 polymorphism (A299G/T399I) was studied in 200 renal transplant patients. Healthy volunteers were also enrolled as control group. The polymorphism analysis was performed using restriction enzymes technique (RFLP). Functionality of TLR-4 polymorphism was assessed in samples from controls by quantification of TNF-alpha after LPS stimulus. TLR-4 and -2 expressions were also analyzed by flow cytometry. Results: TLR-4 polymorphism was present in 8.5% of renal transplant patients. This polymorphism was associated with impairment in TNF-alpha secretion. In general, in renal transplant patients, TLR-4 expression in monocytes and in neutrophils was lower than in health volunteers. TLR-2 and TLR-4 expressions in healthy volunteers with A299G/T399I TLR-4 polymorphism was higher than in wild-type genotype healthy volunteers (p<0.01 and p<0.05, respectively), and also higher than A299G/T399I TLR-4 polymorphism renal transplant patients (p<0.05). TLR-2 expression on neutrophils in wild-type genotype renal transplant patients was higher compared to wild-type genotype healthy volunteers, and was also higher in relation to A299G/T399I kidney transplanted patients (p<0.01). Conclusion: Stable renal transplant patients with TLR-4 polymorphism have a lower expression of TLR-4 and TLR-2 receptors in peripheral mononuclear cells, which ultimately indicate a less responsiveness for alarmins. (C) 2010 Elsevier B.V. All rights reserved.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

State of Sao Paulo Foundation for Research Support (FAPESP)[04/08226-5]

State of Sao Paulo Foundation for Research Support (FAPESP)[07/07139-3]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

State of Sao Paulo Foundation for Research Support (FAPESP)[07/08256-3]

CNPq Brazilian Council of Scientific and Technologic Development

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Complex Fluids INCT

Identificador

INTERNATIONAL IMMUNOPHARMACOLOGY, v.10, n.12, Special Issue, p.1481-1485, 2010

1567-5769

http://producao.usp.br/handle/BDPI/28253

10.1016/j.intimp.2010.09.005

http://dx.doi.org/10.1016/j.intimp.2010.09.005

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

Relação

International Immunopharmacology

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #TLR4 #TLR2 #Polymorphism #Kidney transplant #TOLL-LIKE RECEPTORS #ACUTE ALLOGRAFT-REJECTION #CYTOKINE PRODUCTION #MONOCYTES #INJURY #TOLL-LIKE-RECEPTOR-4 #LIPOPOLYSACCHARIDE #MUTATIONS #DISEASE #CD14 #Immunology #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion